RadNetStock Price and Value Analysis

Should you buy RadNet stock? (NasdaqGM:RDNT). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company is not making money.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

RDNT Free Cash Flow Trend

Hmm, we can't give any reliable projection for RadNet's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for RDNT
Free Cash Flow trendline for RadNet

Inside the RDNT Numbers

RDNT Price
(RadNet stock price per share)
$9.65
[?] PE Ratio versus Sector 150% higher than other Healthcare stocks
[?] PE Ratio versus Industry 74% lower than other Medical Laboratories & Research stocks
[?] Cash Yield 16.76%
[?] Free Cash Flow Jitter 49%

Is RadNet Stock on Sale?

Based on our analysis, we believe that you should not buy RadNet right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy RDNT Stock?

Does RadNet have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.